A new analysis shows that in half of the United States, an incapacitated woman’s advanced directive about health care can be invalidated if she is pregnant.
Judith M. Orvos, ELS
A newly approved drug can significantly reduce the risk of fractures, but it carries a distressing "black box" warning.
Testing circulating concentrations of placental growth factor could improve diagnostic time in suspected preeclampsia cases.
The proposed changes address mammographic technology, enhancing quality standards, and improving the way results of screening are handled throughout the healthcare system.
An analog of an endogenous human hormone has been approved as treatment, but it comes with a steep price tag.
The much-anticipated results of an injectable progestin clinical trial did not align with previous research.
A new study suggests that changes in the fetal brain caused by infections during pregnancy may be linked with autism and possibly depression.
Findings suggest 3D mammography may have advantages over 2D mammography in several areas when it comes to cancer diagnosis in younger women.
New international research offers data that ob/gyns can use to better manage cholestasis in pregnancy and counsel patients about risk of stillbirth associated with the condition.
Referral for counseling is key for women at risk.